Repeatability of Commonly Used Speech and Language Features for Clinical Applications.
Automatic speech analysis
Digital biomarkers
Mobile technology
Repeatability
Speech
Journal
Digital biomarkers
ISSN: 2504-110X
Titre abrégé: Digit Biomark
Pays: Switzerland
ID NLM: 101707633
Informations de publication
Date de publication:
Historique:
received:
22
07
2020
accepted:
16
09
2020
entrez:
14
1
2021
pubmed:
15
1
2021
medline:
15
1
2021
Statut:
epublish
Résumé
Changes in speech have the potential to provide important information on the diagnosis and progression of various neurological diseases. Many researchers have relied on open-source speech features to develop algorithms for measuring speech changes in clinical populations as they are convenient and easy to use. However, the repeatability of open-source features in the context of neurological diseases has not been studied. We used a longitudinal sample of healthy controls, individuals with amyotrophic lateral sclerosis, and individuals with suspected frontotemporal dementia, and we evaluated the repeatability of acoustic and language features separately on these 3 data sets. Repeatability was evaluated using intraclass correlation (ICC) and the within-subjects coefficient of variation (WSCV). In 3 sets of tasks, the median ICC were between 0.02 and 0.55, and the median WSCV were between 29 and 79%. Our results demonstrate that the repeatability of speech features extracted using open-source tool kits is low. Researchers should exercise caution when developing digital health models with open-source speech features. We provide a detailed summary of feature-by-feature repeatability results (ICC, WSCV, SE of measurement, limits of agreement for WSCV, and minimal detectable change) in the online supplementary material so that researchers may incorporate repeatability information into the models they develop.
Identifiants
pubmed: 33442573
doi: 10.1159/000511671
pii: dib-0004-0109
pmc: PMC7772887
doi:
Types de publication
Journal Article
Langues
eng
Pagination
109-122Subventions
Organisme : NIDCD NIH HHS
ID : R01 DC006859
Pays : United States
Informations de copyright
Copyright © 2020 by S. Karger AG, Basel.
Déclaration de conflit d'intérêts
Dr. Visar Berisha is an associate professor at Arizona State University. He is a co-founder of Aural Analytics. Dr. Julie Liss is a professor and associate dean at Arizona State University. She is a co-founder of Aural Analytics. Dr. Jeremy Shefner is the Kemper and Ethel Marley Professor and Chair of Neurology at the Barrow Neurological Institute. He is a scientific advisor to Aural Analytics.
Références
PLoS One. 2019 Mar 27;14(3):e0212342
pubmed: 30917120
Logoped Phoniatr Vocol. 2020 Dec;45(4):151-163
pubmed: 31760837
J Affect Disord. 2018 Jan 1;225:214-220
pubmed: 28841483
J Biomed Opt. 2015 May;20(5):50801
pubmed: 25992845
Mov Disord. 2018 Aug;33(8):1287-1297
pubmed: 29701258
NeuroRehabilitation. 2013;32(3):649-54
pubmed: 23648619
JMIR Mhealth Uhealth. 2019 Aug 01;7(8):e11734
pubmed: 31373275
J Voice. 2008 May;22(3):365-72
pubmed: 17368837
Comput Speech Lang. 2015 Jan;29(1):172-185
pubmed: 25382935
Neurodegener Dis. 2019;19(5-6):163-170
pubmed: 32126556
Amyotroph Lateral Scler Frontotemporal Degener. 2019 Feb;20(1-2):61-67
pubmed: 30486680
Transl Psychiatry. 2016 Jul 19;6:e856
pubmed: 27434490
Stat Med. 2002 Nov 30;21(22):3431-46
pubmed: 12407682
J Alzheimers Dis. 2018;65(2):519-542
pubmed: 30103314
PLoS One. 2019 Nov 7;14(11):e0224365
pubmed: 31697686